• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.

作者信息

Yang Chengzhi, Jin Zening

机构信息

Department of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.

DOI:10.1001/jamacardio.2020.0934
PMID:32211809
Abstract
摘要

相似文献

1
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.一种急性呼吸道感染遭遇了最常见的非传染性流行病——新冠肺炎与心血管疾病。
JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.
2
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.CAPACITY-COVID：一项欧洲登记研究，旨在确定心血管疾病在新冠疫情中的作用。
Eur Heart J. 2020 May 14;41(19):1795-1796. doi: 10.1093/eurheartj/ehaa280.
3
Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients.感染患者中SARS-CoV-2与多种常见呼吸道病原体的合并感染。
Sci China Life Sci. 2020 Apr;63(4):606-609. doi: 10.1007/s11427-020-1668-5. Epub 2020 Mar 5.
4
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.2019年冠状病毒病（COVID-19）与心血管风险：一项荟萃分析。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):527-528. doi: 10.1016/j.pcad.2020.05.001. Epub 2020 May 7.
5
Fear of Coronavirus Disease 2019-An Emerging Cardiac Risk.对2019冠状病毒病的恐惧——一种新出现的心脏风险。
JAMA Cardiol. 2020 Sep 1;5(9):981-982. doi: 10.1001/jamacardio.2020.2890.
6
[Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].[儿童高致病性人类冠状病毒感染的流行病学及临床特征]
Zhonghua Er Ke Za Zhi. 2020 May 2;58(5):351-354. doi: 10.3760/cma.j.cn112140-20200302-00167.
7
[Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19].《新型冠状病毒肺炎疫情期间重症急性心血管疾病患者临床管理原则专家共识》
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 24;48(3):189-194. doi: 10.3760/cma.j.cn112148-20200210-00066.
8
Call to action for the cardiovascular side of COVID-19.针对新冠病毒病心血管方面的行动呼吁。
Eur Heart J. 2020 May 14;41(19):1796-1797. doi: 10.1093/eurheartj/ehaa301.
9
SCAI initiatives during the COVID-19 pandemic.新冠疫情期间的SCAI倡议。
Catheter Cardiovasc Interv. 2020 Nov;96(5):995-996. doi: 10.1002/ccd.29058. Epub 2020 Jun 20.
10
Guidance for Health Care Providers on Management of Cardiovascular Complications in Patients Suspected or Confirmed with COVID 19 Virus Infection.针对疑似或确诊感染新冠病毒患者心血管并发症管理的医疗服务提供者指南。
J Assoc Physicians India. 2020 May;68(5):46-49.

引用本文的文献

1
Association of DHEAS levels with COVID19 severity, gender, age, comorbidities, and management strategies.硫酸脱氢表雄酮（DHEAS）水平与新型冠状病毒肺炎（COVID-19）严重程度、性别、年龄、合并症及治疗策略的关联
Sci Rep. 2025 Jul 1;15(1):21348. doi: 10.1038/s41598-025-05919-9.
2
An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies.深入洞察新冠病毒相关心血管疾病的临床、细胞和分子因素，以确定新型疾病生物标志物、药物靶点和临床管理策略。
Arch Microbiol Immunol. 2024;8(3):290-308. doi: 10.26502/ami.936500177. Epub 2024 Jul 19.
3
Electrocardiographic parameters and mortality in patients with SARS-CoV-2 infection: A single center study.
新型冠状病毒2019感染患者的心电图参数与死亡率：一项单中心研究。
Caspian J Intern Med. 2024 Summer;15(3):444-450. doi: 10.22088/cjim.15.3.444.
4
Factors associated with mortality in patients hospitalized for COVID-19 admitted to a tertiary hospital in Lambayeque, Peru, during the first wave of the pandemic.与秘鲁兰巴耶克三级医院 COVID-19 住院患者死亡相关的因素，在大流行的第一波期间。
PLoS One. 2023 May 11;18(5):e0285133. doi: 10.1371/journal.pone.0285133. eCollection 2023.
5
Self-Measured Blood Pressure Telemonitoring Programs: A Pragmatic How-to Guide.自我测量血压远程监测项目：实用操作指南。
Am J Hypertens. 2023 Jul 14;36(8):417-427. doi: 10.1093/ajh/hpad040.
6
Effects of sociodemographic and health factors on the self-management of non-communicable diseases among Chilean adults during the Covid-19 pandemic.社会人口学和健康因素对新冠疫情期间智利成年人非传染性疾病自我管理的影响。
PLOS Glob Public Health. 2022 Jul 21;2(7):e0000763. doi: 10.1371/journal.pgph.0000763. eCollection 2022.
7
Do selected lifestyle parameters affect the severity and symptoms of COVID-19 among elderly patients? The retrospective evaluation of individuals from the STOP-COVID registry of the PoLoCOV study.选择的生活方式参数是否会影响老年患者 COVID-19 的严重程度和症状？来自 PoLoCOV 研究的 STOP-COVID 登记处的个体的回顾性评估。
J Infect Public Health. 2023 Jan;16(1):143-153. doi: 10.1016/j.jiph.2022.12.008. Epub 2022 Dec 12.
8
The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19.肝素诱导的体外低密度脂蛋白/纤维蛋白原沉淀（H.E.L.P.）血液分离术对重症急性或慢性新冠肺炎患者的治疗潜力
Front Cardiovasc Med. 2022 Oct 11;9:1007636. doi: 10.3389/fcvm.2022.1007636. eCollection 2022.
9
Thromboembolic Disease and Cardiac Thrombotic Complication in COVID-19: A Systematic Review.COVID-19中的血栓栓塞性疾病和心脏血栓并发症：一项系统评价
Metabolites. 2022 Sep 22;12(10):889. doi: 10.3390/metabo12100889.
10
The impact of chronic cardiovascular disease on COVID-19 clinical course.慢性心血管疾病对新冠病毒疾病临床病程的影响。
J Clin Transl Res. 2022 Jul 25;8(4):308-322. eCollection 2022 Aug 29.